Galenica AG has announced it will increase its investment in Puravita AG from 34% to 80%, becoming the majority shareholder as of January 2026. This move is part of Galenica's strategy to strengthen its digital presence and expand its online offerings in the drugstore and over-the-counter sectors. Puravita, a leading Swiss online retailer for pharmacies, drugstores, and health food products, offers over 45,000 items and generates annual net sales of around CHF 22 million. The acquisition allows Galenica to diversify its business beyond traditional pharmacies and further integrate digital and physical services for customers. Puravita will continue to be managed by its founder, Michael Sonderegger.